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CASE REPORT
PAPULAR-PURPURIC “GLOVES AND SOCKS” SYNDROME DUE TO PARVOVIRUS B19:
REPORT OF A CASE WITH UNUSUAL FEATURES
Luiz Fernando C. PASSONI(1), Sayonara R. RIBEIRO(1), Maria Lúcia L. GIORDANI(1), Jacqueline A. MENEZES(1) & Jussara P. NASCIMENTO(2)
SUMMARY
We present a case of papular-purpuric “gloves and socks” syndrome (PPGSS) in an adult male with acute parvovirus B19 infection.
The patient displayed the classical features of fever, oral lesions, and purpura on hands and feet, but the purpuric lesions on the feet
evolved to superficial skin necrosis, a feature not previously described in this syndrome. We believe this is the first reported case of
PPGSS occurring in Brazil.
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INTRODUCTION
The papular-purpuric “gloves and socks” syndrome (PPGSS) was
first described in 1990 by HARMS et al.10 based on clinical features of
five Swiss young adults presenting with a pruritic erythema and edema
of the hands and feet, sharply marginated on the wrists and ankles, rapidly
evolving to petechial purpura associated with fever and oral aphthoid
lesions. The illness was self-limited, lasting 1 to 2 weeks. An infectious
origin, probably viral, was suggested, but could not be proven. In 1991,
BAGOT & REVUZ3 reported a case of PPGSS in a woman with primary
parvovirus B19 infection. Since 1990, more than 50 cases of PPGSS
have been published. In many cases no cause could be found7. B19 is
the only virus clearly established as an etiologic agent of PPGSS9,19,
although occasional cases associated with Coxsackie B virus, measles
virus, cytomegalovirus, hepatitis B virus, Epstein-Barr virus, and human
herpesvirus 6 infection suggest that PPGSS could be a nonspecific
manifestation of a viral infection18. A case of PPGSS developing after
intake of trimethoprim/sulfametoxazol and after re-challenge with the
same drug20, and another one associated with pharyngitis due to
Arcanobacterium haemolyticum8 suggest medications and bacteria as
being other possible, although uncommon, triggers.
We present what we believe to be the first reported case of PPGSS
occurring in Brazil: an adult man with acute B19 infection who displayed
clinical features not previously described in PPGSS.
CASE REPORT
In October 1999, a previously healthy 54-year-old white man was
admitted to the hospital with a five-day history of itching, swelling, and
reddening of the hands, suddenly followed by painful purpuric skin
lesions involving hands and feet. He experienced fatigue, anorexia,
intense myalgia, fever and chills. Sore throat, odynophagia, dysuria,
and painful swelling of the glans penis developed the day before
admission. Prednisone was initiated three days before admission because
a drug reaction had been considered, but brought no clinical improvement.
The patient denied having used any kind of medicine before the onset of
the disease, but reported that his 10-year-old daughter presented with a
febrile rash about ten days before the onset of his illness.
On admission, he was febrile (37.8 oC) with conjunctival injection
and mild jaundice (+/4+). He had multiple grouped vesicles on the upper
lip, a white plaque coating his tongue, buccal enanthema with small
erosions on labial mucosa, and petechiae on the hard palate. A
maculopapular rash was noted on the trunk and extremities with purpuric
lesions on the groins and occasional petechiae on the inner surface of
the thighs. A confluent purpuric-petechial eruption involving both the
palmoplantar and dorsal surfaces of the hands and feet extended to the
wrists and ankles in a “gloves and socks” distribution. Hemorrhagic
bullae were present on the lateral aspects of his feet. His glans penis was
painful, swollen and reddened. The remainder of the physical examination
was unremarkable.
Laboratory tests disclosed the following values: hemoglobin, 16.9
g/dL; leukocytes, 11,200/mm3 (92% granulocytes, 4% lymphocytes, 3%
eosinophils); platelets, 143,000/mm3; erythrocyte sedimentation rate, 5
mm/h; prothrombin and partial thromboplastin times, normal. Serum
chemistry analysis was normal, except for a total bilirubin value of 2.3
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mg/dL (unconjugated bilirubin, 1.8 mg/dL). Blood cultures collected
on admission revealed growth of a coagulase-negative Staphylococcus
in one of three blood samples. A skin biopsy specimen from the left foot
showed extravased red blood cells and a mild perivascular lymphoid
infiltrate, without evidence of vasculitis.
On the fifth day of hospitalization, leukocyte count dropped to 4,280/
mm3 (62% granulocytes, 17% lymphocytes, 12% monocytes, 8%
eosinophils) and serum bilirubin value was normal. The patient’s
condition rapidly improved with conservative treatment, but skin lesions
on the feet changed from purpuric to brown-black with a few areas of
superficial skin necrosis. Two weeks after discharge the patient was well
with scaling of the hands and black eschars replacing the necrotic skin
areas of the feet (Fig. 1). A cell blood count showed 8,400 leukocytes/
mm3, with 27% eosinophils.
Serologic tests were performed in sera from days 7 and 29 of illness.
Serology for syphilis, hepatitis B and C, Epstein-Barr virus (Monotest),
and HIV were negative; serology for measles, rubella, cytomegalovirus,
and herpes simplex virus excluded recent infections. Antistreptolysin O
level in serum from day 29 of illness was 104 IU/mL. Serologic tests for
parvovirus B19 were performed by an “in house” IgM capture enzyme
immunoassay (MACEIA-FIOCRUZ) using native virus antigen16, and
by immunofluorescence to detect B19-specific IgG antibody17. Both
serum specimens yielded B19-specific IgM and IgG antibodies,
confirming an acute B19 infection. B19 DNA was not demonstrated in
serum specimens by dot-blot hybridization assay15.
At the time of the patient’s illness, an outbreak of B19 infection was
occurring in the metropolitan area of Rio de Janeiro5.
COMMENTS
PPGSS is a rare, but clearly defined clinical entity with distinctive
characteristics which permit its rapid recognition and diagnosis, even
considering that diverse acral dermatitis and disorders associated with acral
petechiae have to be considered in the differential diagnosis, such as Gianotti-
Crosti syndrome, atypical measles, rickettsial diseases, Kawasaki disease,
and meningococcemia10,14. Cutaneous manifestations of PPGSS are
characteristic. Initially, edema and erythema appear on the hands and feet in
a “gloves and socks” distribution, followed by isolated or confluent
erythematopapular and purpuric lesions on the same sites, frequently
accompanied by pruritus and pain. In some cases, similar lesions may also
be observed on other sites, including face, trunk, buttocks, groin, elbows,
knees, and thighs21. Systemic symptoms, such as asthenia, headache,
anorexia, and arthralgia usually accompany skin eruptions. Fever occurs
frequently. A variety of oral manifestations have been described, including
pharyngeal erythema, small erosions of the oral mucosa, petechiae and
vesiculopustules on the hard and soft palates, and even Koplik spots6. Genital
mucosa may also be affected, with painful edema and erythema of glans
penis10 and vagina9,11, sometimes with small ulcerations on these sites.
Laboratory findings are nonspecific, with occasional leukopenia, neutropenia,
monocytosis, eosinophilia2, thrombocytopenia, and mild elevations of
transaminase levels7. Histologic findings include edema of the papillary
dermis, extravasation of red blood cells, and a predominantly lymphocytic
perivascular infiltrate, without vasculitis19, although a leucocytoclastic
vasculitis has been demonstrated in some cases14.
The present case is noteworthy because the patient displayed atypical
clinical features of PPGSS. Jaundice noted at presentation has not been
previously reported. The predominantly unconjugated hyper-
Fig. 1 - Scaling of the feet during convalescence of PPGSS: black eschars replace necrotic skin areas.
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bilirubinemia and its spontaneous resolution in a few days could be due
to a clinically inapparent destruction of red blood cell precursors in bone
marrow, due to B19-induced lytic infection of erythroid progenitor cells1,4.
However, Gilbert’s syndrome could not be discarded.
The most striking feature of this patient’s eruption was the presence
of hemorrhagic bullae associated with purpuric lesions on the feet, that
progressed into cutaneous necrosis with superficial ulcerations. Purpura
associated with skin necrosis and superficial ulcerations was reported in
a case of arthritis and vasculitis due to B19 infection13. Although some
PPGSS patients develop desquamation of the involved areas as the
syndrome resolves21, healing with thick black eschars has not to our
knowledge been previously described in this syndrome.
B19 infection has been associated with a broad spectrum of
dermatological and systemic problems, that vary with the age and clinical
conditions of the host, and include erythema infectiosum, polyarticular
arthralgias and arthritis, transient aplastic crisis in persons who have
underlying hemolytic anemia, hydrops fetalis and fetal death, and chronic
anemia resulting from persistent infection in immune compromised
patients12. Acute B19 infection may be an asymptomatic or subclinical
infection, or may manifest as a biphasic illness with symptoms during
the viremic and immune complex-mediated stages of the disease.
In experimental parvoviral infection in humans1, B19 DNA is detected
in serum by dot-blot hybridization after the sixth day from the intranasal
inoculation of the virus and may be detected for up to seven days
thereafter. A B19-specific IgM response develops during the second week
after inoculation whereas IgG develops at the end of the second week
and early in the third week after inoculation1. Since B19 DNA is
detectable in serum by dot-blot hybridization for only a few days, and,
on the other hand, by polymerase chain reaction for more than 4 months
after acute infection, the diagnosis of acute B19 infection in
immunocompetent persons is based on serologic assays for B19-specific
IgM4. Several commercial tests for specific IgM have been developed
and used to diagnose acute infection. These tests can produce false
positive and false negative results, and IgM detection using native antigen
in a capture assay format should be therefore performed as a confirmatory
test. In acute B19 infection, the capture assay by enzyme immunoassay
(MACEIA-FIOCRUZ) has been 100% concordant with the referential
capture assay by radioimmunoassay (MACRIA-CPHL-UK)16.
In the present case, both B19-specific IgG and IgM were detected in
sera from days 7 and 29 of illness. B19 DNA was not detected in sera by
dot-blot hybridization, as expected as the patient had already mounted
an antibody response at that time15. The diagnosis of acute B19 infection
was reinforced because the patient lived in a community known to be
experiencing an outbreak of B19 infection5, and by the fact that his
daughter had an exanthematic disease days before the onset of his illness.
In Rio de Janeiro, incidence of B19 cases peaks between August and
November, with outbreaks occurring at 5-year intervals5.
The pathogenesis of PPGSS remains incompletely defined. In the
cases associated with B19 infection, the virus has been found in the
endothelial cells of skin vessels and cells of the basal epidermis at the
time of the exanthem, which suggests that the rash is directly related to
viral presence2,9. However, it is not known whether the rash is a
manifestation of primary viremia or a consequence of immune complex
formation19. In several B19-related PPGSS cases, B19-specific IgM
antibody has not been demonstrated in serum at the time of the initial
presentation with rash and pruritus, suggesting that the mucocutaneous
lesions develop during the period of viremia2,19,21. In the present case,
both B19-specific IgG and IgM were detected in serum collected on the
seventh day of illness, which might suggest that the rash occurred when
an antibody response had already developed. This finding is similar to
that observed in patients with erythema infectiosum, in whom IgG and
IgM are detected in serum at the time of the rash, and contrasts to that
observed in patients with transient aplastic crisis, in whom B19 DNA is
detected in serum by dot-blot hybridization, and IgM but not IgG
antibodies may be detected at the time of the aplastic crisis4,17.
This case report illustrates the variability of clinical features displayed
by B19 infection, emphasizes the need of further investigations into the
pathogenesis of PPGSS, and reinforces B19 as the principal etiologic
agent of PPGSS.
RESUMO
Síndrome purpúrico-papular em “luvas e meias” por parvovírus
B19: relato de caso
Um caso de síndrome purpúrico-papular em “luvas e meias” devido
à infecção aguda por parvovírus B19 é descrito em um homem adulto
que, além das manifestações clássicas de febre, lesões orais e púrpura
em mãos e pés, evoluiu com icterícia e necrose cutânea superficial dos
pés, características até então não descritas nesta síndrome. Acreditamos
tratar-se do primeiro caso descrito no Brasil.
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